Learn how Repatha®, a PCSK9 inhibitor, can reduce the risk of myocardial infarction, stroke or coronary revascularization in your patients with established CVD.

The recommended subcutaneous dosage of REPATHA in patients with HoFH is 420 mg once monthly. In patients with HoFH, measure LDL-C levels 4 to 8 weeks after starting REPATHA, …

Repatha ® actúa de manera rápida para bajar el colesterol malo (LDL-C) drásticamente. Al agregar Repatha ® a una pastilla de estatina, los pacientes pudieron lograr una reducción …

REPATHA es una solución inyectable de evolocumab, utilizada para el tratamiento de enfermedades cardiovasculares y reducción de colesterol.

Publicado: 17:08:38. The Regional Manager at Amgen oversees a team of sales representatives. They are responsible for…Ve este y otros empleos similares en LinkedIn.

For patients already enrolled in Amgen’s co-pay program, enter your information below to retrieve your co-pay card number. All information entered must be an exact match to the information …

Descubra cómo usar el autoinyector SureClick® y el sistema Pushtronex® de Repatha®, así como otra información útil sobre la administración y conservación. Consulte la información …

Publicado: 14:43:27. The District Manager oversees sales activities within a specific geographical district. They manage…Ve este y otros empleos similares en LinkedIn.

Find patient applications along with provider forms such as product prescription forms, on demand product request forms and product replacement request forms.

Be ready for your treatment with Repatha ®! Immediately upon your enrolment, the RepathaREADY ® Program begins to provide personalized services and support throughout …